Research reveals how psychedelics reshape communication between the brain and immune system
- Dr. Michael Wheeler and his team published a Nature study on April 23, 2025, revealing that psychedelics reshape brain-immune communication to reduce fear and stress responses.
- This research builds on findings that chronic stress disrupts amygdala signaling, triggering immune cell-driven inflammation that heightens fear behavior.
- The study showed psychedelics block immune cells from accumulating in the brain, interrupting inflammatory cascades and lowering fear, supported by mouse models and human gene data.
- The authors wrote, "psychedelic compounds can reverse this entire process," suggesting new treatment possibilities for depression and fear-based disorders.
- These insights imply a paradigm shift in treating neuropsychiatric disorders by focusing on brain-immune interactions, but researchers caution psychedelics are not cure-alls and call for more study.
11 Articles
11 Articles
Research reveals how psychedelics reshape communication between the brain and immune system
In a compelling Genomic Press interview published today, rising scientific star Dr. Michael Wheeler unveils revolutionary findings about how psychedelics reshape communication between the brain and immune system, potentially transforming treatments for psychiatric disorders and inflammatory diseases alike.
Parkinson's patients who take 'magic mushrooms' see key benefits, study finds – Democratic Accent
As Parkinson’s cases continue to rise, the race is on for therapies to combat the effects of the disease — and researchers have pinpointed an unlikely source of relief. Psilocybin, a psychedelic compound found in some mushrooms, has been found to improve mood, cognition and motor symptoms in Parkinson’s patients, according to a new study from the University of California San Francisco (UCSF). The substance, often referred to as “magic mushrooms,…
Coverage Details
Bias Distribution
- 67% of the sources are Center
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage